Cargando…

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma

Detalles Bibliográficos
Autores principales: Mithraprabhu, Sridurga, Reynolds, John, Turner, Rose, Quach, Hang, Horvath, Noemi, Kerridge, Ian, Kalff, Anna, Bergin, Krystal, Hocking, Jay, Yuen, Flora, Khong, Tiffany, Durie, Brian M., Spencer, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925790/
https://www.ncbi.nlm.nih.gov/pubmed/36781844
http://dx.doi.org/10.1038/s41408-023-00796-9
_version_ 1784888132364140544
author Mithraprabhu, Sridurga
Reynolds, John
Turner, Rose
Quach, Hang
Horvath, Noemi
Kerridge, Ian
Kalff, Anna
Bergin, Krystal
Hocking, Jay
Yuen, Flora
Khong, Tiffany
Durie, Brian M.
Spencer, Andrew
author_facet Mithraprabhu, Sridurga
Reynolds, John
Turner, Rose
Quach, Hang
Horvath, Noemi
Kerridge, Ian
Kalff, Anna
Bergin, Krystal
Hocking, Jay
Yuen, Flora
Khong, Tiffany
Durie, Brian M.
Spencer, Andrew
author_sort Mithraprabhu, Sridurga
collection PubMed
description
format Online
Article
Text
id pubmed-9925790
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99257902023-02-15 Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma Mithraprabhu, Sridurga Reynolds, John Turner, Rose Quach, Hang Horvath, Noemi Kerridge, Ian Kalff, Anna Bergin, Krystal Hocking, Jay Yuen, Flora Khong, Tiffany Durie, Brian M. Spencer, Andrew Blood Cancer J Correspondence Nature Publishing Group UK 2023-02-13 /pmc/articles/PMC9925790/ /pubmed/36781844 http://dx.doi.org/10.1038/s41408-023-00796-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Mithraprabhu, Sridurga
Reynolds, John
Turner, Rose
Quach, Hang
Horvath, Noemi
Kerridge, Ian
Kalff, Anna
Bergin, Krystal
Hocking, Jay
Yuen, Flora
Khong, Tiffany
Durie, Brian M.
Spencer, Andrew
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_full Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_fullStr Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_full_unstemmed Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_short Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_sort circulating tumour dna analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925790/
https://www.ncbi.nlm.nih.gov/pubmed/36781844
http://dx.doi.org/10.1038/s41408-023-00796-9
work_keys_str_mv AT mithraprabhusridurga circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT reynoldsjohn circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT turnerrose circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT quachhang circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT horvathnoemi circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT kerridgeian circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT kalffanna circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT berginkrystal circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT hockingjay circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT yuenflora circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT khongtiffany circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT duriebrianm circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT spencerandrew circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma